search
Back to results

Support for Adolescents Living With HIV in South Africa (InTSHA VIP)

Primary Purpose

Human Immunodeficiency Virus, HIV

Status
Not yet recruiting
Phase
Not Applicable
Locations
South Africa
Study Type
Interventional
Intervention
In-person adolescent-friendly service (iPAS) intervention
mHealth (InTSHA) intervention
Standard of Care
Sponsored by
Emory University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Human Immunodeficiency Virus focused on measuring transition of care, adolescent

Eligibility Criteria

15 Years - 19 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria for Adolescent Participants: Aged 15 to 19 years at enrollment Living with perinatally-acquired HIV Receiving ART for at least 6 months Aware of their HIV status Scoring low to intermediate on transition readiness assessment (intervention cohort only) Inclusion Criteria for Healthcare Providers: Profession as a healthcare provider Working at one of the designated clinics Involvement with adolescents before, during or after transition to adult care Exclusion Criteria for all participants: Inability to read and/or speak English or Zulu Severe mental or physical illness preventing participation in informed consent activities Anticipated move out of clinic area in the next 12 months

Sites / Locations

  • King Edward VIII Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm Type

Experimental

Experimental

Active Comparator

No Intervention

No Intervention

Arm Label

In-person adolescent-friendly service (iPAS) intervention:

mHealth (InTSHA) intervention

Standard of Care/Delayed Intervention

Healthcare Providers

Observational cohort

Arm Description

Adolescents at study clinics who score low or intermediate on transition readiness during screening will be invited to enroll in the study. Adolescents attending clinics randomized to the in-person supported adolescent friendly services will attend their clinic after school hours on a designated day or on weekends dedicated for adolescent care monthly for 9 months.

Adolescents at study clinics who score low or intermediate on transition readiness during screening will be invited to enroll in the study. Adolescents attending clinics randomized to the mHealth intervention will receive the InTSHA intervention based in the Got Transition elements and the SMART model for 9 months.

Adolescents at study clinics who score low or intermediate on transition readiness during screening will be invited to enroll in the study. Adolescents attending clinics randomized to deliver the standard of care before transitioning to adult care in their standard local adult clinic. Participants will be invited to receive the intervention the clinic is randomized to deliver when the 9 month period of administering the standard of care is complete.

Healthcare providers working at one of study clinics, administering the study intervention selected for that clinic.

Adolescents at study clinics who score high on transition readiness during screening will not be invited to enroll in the study but will be asked for their consent to have their clinic records reviewed for medical records, retention data and transition readiness data. They will also complete a questionnaire at Months 9, 18, and 24.

Outcomes

Primary Outcome Measures

Number of Participants Retained in Care
Clinic patients are considered to be retained in care if 80% of ART pharmacy refills are filled on time (< 7days from scheduled date) and 80% of scheduled clinic appointments are attended.
Change in Number of Participants with Viral Suppression
HIV-1 viral load is measured in viral copies per milliliter (mL) of blood and viral suppression is defined as <200 copies/ml.

Secondary Outcome Measures

Change in Acceptability of Intervention Measure (AIM) Score
Acceptability of the intervention is assessed with the AIM questionnaire. The AIM questionnaire has 4 items asking respondents how much they agree with statements such as "the intervention is appealing to me". Responses are given on a 5-point scale where "completely disagree" = 1 and "completely agree" = 5. Total scores range from 4 to 20 where higher scores indicate greater feelings of acceptability.
Change in Intervention Appropriateness Measure (IAM) Score
Appropriateness of the intervention is assessed with the IAM questionnaire. The IAM questionnaire has 4 items asking respondents how much they agree with statements such as "the intervention seems applicable". Responses are given on a 5-point scale where "completely disagree" = 1 and "completely agree" = 5. Total scores range from 4 to 20 where higher scores indicate greater feelings that the intervention is appropriate.
Change in Feasibility of Intervention Measure (FIM) Score
Feasibility of the intervention is assessed with the FIM questionnaire. The FIM questionnaire has 4 items asking respondents how much they agree with statements such as "the intervention seems possible". Responses are given on a 5-point scale where "completely disagree" = 1 and "completely agree" = 5. Total scores range from 4 to 20 where higher scores indicate greater feelings that the intervention is feasible.
Change in HIV Adolescent Readiness for Transition Scale (HARTS) Score
The HIV Adolescent Readiness for Transition Scale (HARTS) includes 16 items that are responded to on a 5-point scale where 0 = no, 1 = no, but I am learning, 2 = yes, a little bit, 3 = yes, almost always, and 4 = yes, always. Total scores range from 0 to 64 and higher scores indicate greater readiness to transition to adult care.
Change in Participation Rate
Adoption of the intervention is examined as the number of adolescent patients enrolling in the study. Adoption of the intervention is considered successful with a participation rate threshold of >70%.
Change in Intervention Fidelity
Healthcare providers will complete an intervention checklist monthly during the intervention. A threshold of >80% of intervention checklist items is considered to be fidelity to the intervention.
Cost of the Intervention
Cost of the intervention is assessed through time and motions studies. Time and motion studies involve counting the time a healthcare provider takes to prepare and deliver the intervention and how long (in hours) each session takes.
Intervention Completion Rate
Completion of the intervention is examined as the number of adolescent participants who complete the study.
Change in Attendance to Clinic Visits
Sustained effectiveness of the study is examined as attendance to clinic visits post-transitioning to care through an adult clinic.
Change in Pharmacy Refills
Sustained effectiveness of the study is examined as pharmacy refills post-transitioning to care through an adult clinic.

Full Information

First Posted
September 6, 2023
Last Updated
September 6, 2023
Sponsor
Emory University
Collaborators
University of KwaZulu, National Institute of Mental Health (NIMH)
search

1. Study Identification

Unique Protocol Identification Number
NCT06035445
Brief Title
Support for Adolescents Living With HIV in South Africa
Acronym
InTSHA VIP
Official Title
Interactive Transition Support for Adolescents Living With HIV Comparing Virtual and In-person Delivery Through a Stepped-wedge Cluster Randomized Clinical Trial in South Africa
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
November 1, 2023 (Anticipated)
Primary Completion Date
December 31, 2027 (Anticipated)
Study Completion Date
December 31, 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Emory University
Collaborators
University of KwaZulu, National Institute of Mental Health (NIMH)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a cluster randomized controlled trial determining the effectiveness of in-person or mHealth-based adolescent-friendly transition interventions compared to standard care on retention in care and viral suppression among adolescents living with HIV who have low transition readiness. Participants are adolescents living with HIV ages 15 to 19 years old in KwaZulu-Natal, South Africa.
Detailed Description
South Africa has the highest number of adolescents living with HIV in the world, yet adolescents are poorly prepared for transition from pediatric to adult services. For a large majority of South Africans living with HIV, antiretroviral therapy (ART) was not available until 2004. This delay contributed to nearly 500,000 perinatal HIV infections in the late 1990s and early 2000s. With large scale-up efforts and improved access to ART in recent years, survivors of perinatal HIV infection are now reaching adolescence and beyond. As the wave of adolescents living with perinatally-acquired HIV matures, an estimated 320,000 adolescents will transfer from pediatric- or adolescent-based clinics to adult services in the next 10 years in South Africa. Although the mother-to-child HIV transmission rates in South Africa have decreased to less than 2%, thousands of infants are still being born with HIV each year ensuring that adolescent HIV will be an issue for many years. Currently, adolescents living with perinatally-acquired HIV enter adult care at variable ages and developmental stages, typically without necessary preparation or support through the process. The transition from pediatric to adult services for adolescents living with HIV is a critically vulnerable time during which there is a high risk for disengagement from care and resultant morbidity and mortality. Despite an overall decrease in global HIV-related mortality, HIV remains the leading cause of death among adolescents living in South Africa where less than 50% of adolescents living with HIV are virally suppressed. Globally, disruptions related to transitioning from pediatric to adult care have been associated with high rates of HIV drug resistance, virologic failure, progression to AIDS and mortality. In South Africa, older adolescents (>15 years old) had lower viral suppression rates than younger adolescents at the time of transfer to general clinics. Studies of in-person adolescent support groups (teen/adherence clubs) and adolescent-friendly services have shown mixed results in mitigating the poor outcomes of adolescents living with HIV. In-person adherence clubs have improved long-term adherence to ART among adults. However, the adherence or teen club models among adolescents living with HIV have shown mixed results. The delivery of healthcare through portable mobile devices (mHealth) interventions have potential to remedy the challenges along the HIV continuum of care faced by adolescents living with HIV but larger, adequately powered randomized trials are needed. Adolescents in South Africa commonly communicate via social media to gain social support and health information from their peers and the use of social media for health expanded during the coronavirus infection 2019 (COVID-19) pandemic. mHealth strategies thus provides the opportunity to reach adolescents regularly using a preferred format, which could be utilized to improve the reach and impact of adolescent-focused interventions. The Social-ecological Model of Adolescent and Young Adult Readiness to Transition (SMART) highlights modifiable targets of intervention that can improve transition care for adolescents living with HIV. The SMART model incorporates modifiable factors such as knowledge, skills/self-efficacy, relationships, and social support that can be targets of interventions to improve transition care. Medical care during adolescence is typically complicated by increased risk-taking behavior, as well as decreased caregiver involvement, which occur during a time of rapid physical, emotional, and cognitive development. When adolescents transition to adult care, they often do not receive the coordinated services that they received under pediatric care. The SMART model emphasizes eight modifiable factors, three key stakeholders (adolescents, caregivers, and clinicians) and their interconnected relationship in influencing successful transition to adult care. Using the SMART model, interventions delivered in-person or virtually can address the modifiable factors in the model to improve transition care for adolescents living with HIV but rigorous clinical trials are needed to prove effectiveness. The researchers have developed and validated the first transition readiness assessment for adolescents living with HIV in South Africa and demonstrated its utility in predicting viral suppression in adult care. Through the development and validation of the HIV Adolescent Readiness to Transition Scale (HARTS) the researchers found that higher ratings reflecting HIV disclosure, healthcare navigation, self-advocacy, and health literacy were predictive of viral suppression after transition to adult care for adolescents living with HIV in South Africa. Using the HARTS in addition to demographic data associated with viral suppression after transition to adult care, the researchers created a transition readiness score to assist clinicians in determining which adolescents may benefit from additional services prior to transitioning to adult care. Clinics in KwaZulu-Natal, South Africa are randomized to deliver an in-person adolescent-friendly service (iPAS) intervention, mHealth InTSHA intervention, or standard of care to adolescents receiving care at those clinics who score low or intermediate when screened for transition readiness. After the first 9 months of the study, the clinics randomized to deliver standard of care will begin delivering either the iPAS or InTSHA interventions for the next 9 month period. Adolescents participate in the intervention occurring at the clinic they attend for 9 months and complete surveys at baseline, after the 9 month intervention, and a final survey at the end of the study (15 or 24 months after enrollment). Adolescents with high scores when screened for transition readiness will comprise an observational cohort where data will be abstracted from medical records and they will complete questionnaires at 9, 18, and 24 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Human Immunodeficiency Virus, HIV
Keywords
transition of care, adolescent

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This study uses a stepped-wedge, delayed implementation randomized clinical trial design, to measure the effectiveness of the interventions compared to standard of care.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1000 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
In-person adolescent-friendly service (iPAS) intervention:
Arm Type
Experimental
Arm Description
Adolescents at study clinics who score low or intermediate on transition readiness during screening will be invited to enroll in the study. Adolescents attending clinics randomized to the in-person supported adolescent friendly services will attend their clinic after school hours on a designated day or on weekends dedicated for adolescent care monthly for 9 months.
Arm Title
mHealth (InTSHA) intervention
Arm Type
Experimental
Arm Description
Adolescents at study clinics who score low or intermediate on transition readiness during screening will be invited to enroll in the study. Adolescents attending clinics randomized to the mHealth intervention will receive the InTSHA intervention based in the Got Transition elements and the SMART model for 9 months.
Arm Title
Standard of Care/Delayed Intervention
Arm Type
Active Comparator
Arm Description
Adolescents at study clinics who score low or intermediate on transition readiness during screening will be invited to enroll in the study. Adolescents attending clinics randomized to deliver the standard of care before transitioning to adult care in their standard local adult clinic. Participants will be invited to receive the intervention the clinic is randomized to deliver when the 9 month period of administering the standard of care is complete.
Arm Title
Healthcare Providers
Arm Type
No Intervention
Arm Description
Healthcare providers working at one of study clinics, administering the study intervention selected for that clinic.
Arm Title
Observational cohort
Arm Type
No Intervention
Arm Description
Adolescents at study clinics who score high on transition readiness during screening will not be invited to enroll in the study but will be asked for their consent to have their clinic records reviewed for medical records, retention data and transition readiness data. They will also complete a questionnaire at Months 9, 18, and 24.
Intervention Type
Behavioral
Intervention Name(s)
In-person adolescent-friendly service (iPAS) intervention
Intervention Description
Monthly visits take place in a group setting with sessions led by peer educators. Clinical staff and peer educators are trained in care of adolescents using the Right to Care training materials. During their clinic visit, adolescents are evaluated individually by a healthcare provider and receive their supply of ART. In addition, adolescents participate in scheduled group team-building activities including dancing, sports, music and receive group counseling facilitated by peer educators. Nine group counseling sessions will discuss the topics of: HIV disclosure, alcohol and substance abuse, HIV knowledge, ART adherence and HIV resistance, goal setting and career planning, sexual and reproductive health, HIV stigma, healthcare navigation and self-advocacy, and healthy relationships. The half-day sessions will end with the provision of a meal. After completion of the 9-month intervention, adolescents will transition to adult care in their standard local adult clinic.
Intervention Type
Behavioral
Intervention Name(s)
mHealth (InTSHA) intervention
Intervention Description
The InTSHA intervention is based on Got Transition elements (two-way messaging between adolescents and healthcare providers) and the SMART model. The SMART model focuses on modifiable factors of transition preparation through content delivery, facilitated discussions, online meet ups and consultation with the healthcare team. The intervention consists of 9 modules delivered monthly by group chat. The topics of the modules are: HIV disclosure, alcohol and substance abuse, HIV knowledge, ART adherence and HIV resistance, goal setting and career planning, sexual and reproductive health, HIV stigma, healthcare navigation and self-advocacy, and healthy relationships. Outside of scheduled group chat sessions, adolescents have access to the chat group to check in with members, review content of the sessions, or to comment or ask additional questions. After completion of the 9-month intervention, adolescents will transition to adult care in their standard local adult clinic.
Intervention Type
Behavioral
Intervention Name(s)
Standard of Care
Intervention Description
Adolescents in standard of care are seen every three months by clinicians and collect medication monthly at an on-site pharmacy during regular weekdays. Individual counseling delivered by counselors or social workers is available when necessary. Staff at all clinics receive training in adolescent-friendly services (AFS) through the Right to Care training materials.
Primary Outcome Measure Information:
Title
Number of Participants Retained in Care
Description
Clinic patients are considered to be retained in care if 80% of ART pharmacy refills are filled on time (< 7days from scheduled date) and 80% of scheduled clinic appointments are attended.
Time Frame
After the 9 month intervention (Month 9 or Month 18)
Title
Change in Number of Participants with Viral Suppression
Description
HIV-1 viral load is measured in viral copies per milliliter (mL) of blood and viral suppression is defined as <200 copies/ml.
Time Frame
Baseline, After the 9 month intervention (Month 9 or Month 18)
Secondary Outcome Measure Information:
Title
Change in Acceptability of Intervention Measure (AIM) Score
Description
Acceptability of the intervention is assessed with the AIM questionnaire. The AIM questionnaire has 4 items asking respondents how much they agree with statements such as "the intervention is appealing to me". Responses are given on a 5-point scale where "completely disagree" = 1 and "completely agree" = 5. Total scores range from 4 to 20 where higher scores indicate greater feelings of acceptability.
Time Frame
Baseline, After the 9 month intervention (Month 9 or Month 18)
Title
Change in Intervention Appropriateness Measure (IAM) Score
Description
Appropriateness of the intervention is assessed with the IAM questionnaire. The IAM questionnaire has 4 items asking respondents how much they agree with statements such as "the intervention seems applicable". Responses are given on a 5-point scale where "completely disagree" = 1 and "completely agree" = 5. Total scores range from 4 to 20 where higher scores indicate greater feelings that the intervention is appropriate.
Time Frame
Baseline, After the 9 month intervention (Month 9 or Month 18)
Title
Change in Feasibility of Intervention Measure (FIM) Score
Description
Feasibility of the intervention is assessed with the FIM questionnaire. The FIM questionnaire has 4 items asking respondents how much they agree with statements such as "the intervention seems possible". Responses are given on a 5-point scale where "completely disagree" = 1 and "completely agree" = 5. Total scores range from 4 to 20 where higher scores indicate greater feelings that the intervention is feasible.
Time Frame
Baseline, After the 9 month intervention (Month 9 or Month 18)
Title
Change in HIV Adolescent Readiness for Transition Scale (HARTS) Score
Description
The HIV Adolescent Readiness for Transition Scale (HARTS) includes 16 items that are responded to on a 5-point scale where 0 = no, 1 = no, but I am learning, 2 = yes, a little bit, 3 = yes, almost always, and 4 = yes, always. Total scores range from 0 to 64 and higher scores indicate greater readiness to transition to adult care.
Time Frame
Baseline, Month 9, Month 18, Month 24
Title
Change in Participation Rate
Description
Adoption of the intervention is examined as the number of adolescent patients enrolling in the study. Adoption of the intervention is considered successful with a participation rate threshold of >70%.
Time Frame
Baseline, After the 9 month intervention (Month 9 or Month 18)
Title
Change in Intervention Fidelity
Description
Healthcare providers will complete an intervention checklist monthly during the intervention. A threshold of >80% of intervention checklist items is considered to be fidelity to the intervention.
Time Frame
Up to Month 24
Title
Cost of the Intervention
Description
Cost of the intervention is assessed through time and motions studies. Time and motion studies involve counting the time a healthcare provider takes to prepare and deliver the intervention and how long (in hours) each session takes.
Time Frame
After the 9 month intervention (Month 9 or Month 18)
Title
Intervention Completion Rate
Description
Completion of the intervention is examined as the number of adolescent participants who complete the study.
Time Frame
After the 9 month intervention (Month 9 or Month 18)
Title
Change in Attendance to Clinic Visits
Description
Sustained effectiveness of the study is examined as attendance to clinic visits post-transitioning to care through an adult clinic.
Time Frame
Month 18, Month 24
Title
Change in Pharmacy Refills
Description
Sustained effectiveness of the study is examined as pharmacy refills post-transitioning to care through an adult clinic.
Time Frame
Month 18, Month 24
Other Pre-specified Outcome Measures:
Title
Change in Child and Adolescent Social Support Scale (CASSS) Score
Description
Social support from peers is assessed using 10 items of the Child and Adolescent Social Support Scale (friend support subscale). Responses are given on a 6-point scale where 1 = never and 6 = always. Total scores range from 10 to 60, where higher scores represent greater social support from peers.
Time Frame
Baseline, After the 9 month intervention (Month 9 or Month 18)
Title
Change in Rosenberg's Self-Esteem Scale Score
Description
The Rosenberg's Self-Esteem Scale is a 10-item instrument assessing self-esteem. Responses are given on a 4-point scale where 0 = strongly disagree and 3 = strongly agree. Total scores range 0 to 30 and higher scores indicate greater self-esteem.
Time Frame
Baseline, After the 9 month intervention (Month 9 or Month 18)
Title
Change in Patient Health Questionnaire (PHQ-9) Score
Description
The PHQ-9 is a 9-item self-report questionnaire developed to identify patients at risk for depression. Participants report how often they have been bothered by specific symptoms of depression on a scale of 0 (not at all) to 3 (nearly every day). Higher scores indicate greater symptoms of depression. A score of ≥ 9 indicates clinically significant symptoms.
Time Frame
Baseline, After the 9 month intervention (Month 9 or Month 18)
Title
Change in Internalized AIDS-Related Stigma Scale (IA-RSS) Score
Description
The IA-RSS assesses several dimensions of stigma concerning HIV status. The instrument includes 6 items adapted form the AIDS-Related Stigma scale. Statements about hesitancy to disclose HIV status and feelings of shame are responded to as 0 = Disagree and 1 = Agree. Total scores range from 0 to 6 with higher scores indicating increased internalized stigma.
Time Frame
Baseline, After the 9 month intervention (Month 9 or Month 18)
Title
Change in Working Alliance Inventory (WAI) Score
Description
connection to clinic (Working Alliance Inventory) A modified version of the Working Alliance Inventory is used to measure how connected participants feel to the clinical staff and medical team. Ten items are responded to on a 4-point scale where 0 = strongly disagree and 3 = strongly agree. Total scores range from 0 to 30 where higher scores indicate increased feelings of connection with clinical staff.
Time Frame
Baseline, After the 9 month intervention (Month 9 or Month 18)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
15 Years
Maximum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria for Adolescent Participants: Aged 15 to 19 years at enrollment Living with perinatally-acquired HIV Receiving ART for at least 6 months Aware of their HIV status Scoring low to intermediate on transition readiness assessment (intervention cohort only) Inclusion Criteria for Healthcare Providers: Profession as a healthcare provider Working at one of the designated clinics Involvement with adolescents before, during or after transition to adult care Exclusion Criteria for all participants: Inability to read and/or speak English or Zulu Severe mental or physical illness preventing participation in informed consent activities Anticipated move out of clinic area in the next 12 months
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Brian C Zanoni, MD, MPH
Phone
404-727-0284
Email
brian.christopher.zanoni@emory.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Thobe Sibaya
Phone
071-378-2271
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Brian C Zanoni, MD, MPH
Organizational Affiliation
Emory University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Mohendran Archary, MBchB
Organizational Affiliation
King Edward VIII Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
King Edward VIII Hospital
City
Congella
Country
South Africa
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mohendran Archary, MBchB
Phone
031-260-4318
First Name & Middle Initial & Last Name & Degree
Mohendran Archary, MBChB

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
De-identified, individual participant data will be made available for sharing, including demographic information, clinic information, and study and survey data.
IPD Sharing Time Frame
Data will be made available for sharing following publication of results from this study.
IPD Sharing Access Criteria
Data will be made available for sharing through the Emory Dataverse. The Dataverse website can be accessed by any researcher for secondary analyses.

Learn more about this trial

Support for Adolescents Living With HIV in South Africa

We'll reach out to this number within 24 hrs